Company Encyclopedia
View More
name
FlexShares Dev Mrkts ex-US Quality Low Volatility Indx Fd
QLVD.US
News
View More

Sanofi Expands Vaccine Portfolio and Gains China Approval for Rare Disease Drugs

Sanofi has expanded its vaccine portfolio by acquiring Vicebio Ltd, introducing a new combination vaccine candidate for RSV and HMPV. Additionally, Sanofi received approval in China for rare disease drugs Qfitlia and Cablivi, enhancing its market reach. Analysts rate Sanofi stock as a Buy with a $56.00 target, supported by strong earnings and financial stability. Sanofi is a biopharmaceutical company focused on innovative medicines and vaccines, publicly traded on EURONEXT and NASDAQ.

Tip Ranks·
US
SNY
-0.37%
US
SNYNF
+1.29%
Tip Ranks·
US
SNY
-0.37%
US
SNYNF
+1.29%

Sanofi Completes Acquisition of Vicebio

Sanofi has completed its acquisition of Vicebio Ltd, enhancing its vaccine portfolio with an early-stage candidate for RSV and HMPV. This acquisition also incorporates Vicebio's 'Molecular Clamp' technology, strengthening Sanofi's position in respiratory vaccines and offering a non-mRNA option. The original content was published by Sanofi SA via EDGAR on December 12, 2025.

Reuters·
US
SNY
-0.37%
US
SNYNF
+1.29%
Reuters·
US
SNY
-0.37%
US
SNYNF
+1.29%

Sanofi Wins China Approval for Qfitlia and Cablivi in Rare Blood Disorders

Sanofi SA has received approval from China's NMPA for Qfitlia and Cablivi, expanding its rare hematology portfolio. Qfitlia is the first antithrombin-lowering therapy for hemophilia in China, requiring only six injections annually. Cablivi, the first Nanobody medicine approved in China, treats the rare blood disorder aTTP/iTTP. These approvals address unmet needs for chronic bleeding disorders and acute clotting emergencies.

Reuters·
US
SNYNF
+1.29%
Reuters·
US
SNYNF
+1.29%

Nestle India says Svetlana Boldina to relinquish CFO role effective Jan 31, 2026

Nestle India says Svetlana Boldina to relinquish CFO role effective Jan 31, 2026

marketscreener·
US
NSRGY
+0.20%
US
NSRGF
+0.30%
marketscreener·
US
NSRGY
+0.20%
US
NSRGF
+0.30%

Nestle India's finance chief to step down

Nestle India's finance chief to step down

marketscreener·
US
NSRGF
+0.30%
US
NSRGY
+0.20%
marketscreener·
US
NSRGF
+0.30%
US
NSRGY
+0.20%
© 2025 Longbridge｜Disclaimer